Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial
Jump to section
Related Articles
Cited By...
- Bronchopulmonary dysplasia: a crime of opportunity?
- Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
- Spontaneous Closure of Patent Ductus Arteriosus in Infants <=1500 g
- Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby
- Patent Ductus Arteriosus in Preterm Infants
- Relative Adrenal Insufficiency in Premature Infants: State of the Art
- Inotrope and Vasopressor Support in Neonates
- Prophylactic Indomethacin and Intestinal Perforation in Extremely Low Birth Weight Infants
- Postnatal epigenetic modification of glucocorticoid receptor gene in preterm infants: a prospective cohort study
- Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age
- Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
- Aiming for Zero: Preventing Invasive Candida Infections in Extremely Preterm Infants
- Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
- Patent Ductus Arteriosus of the Preterm Infant
- Medicines used in respiratory diseases only seen in children
- Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia
- Histological chorioamnionitis and respiratory outcome in preterm infants
- Do Cortisol Concentrations Predict Short-Term Outcomes in Extremely Low Birth Weight Infants?
- Fetal cortisol response to intrauterine microbial colonisation identified by the polymerase chain reaction and fetal inflammation
- Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up
- Maternal Factors in Extremely Low Birth Weight Infants Who Develop Spontaneous Intestinal Perforation
- Patent ductus arteriosus: lack of evidence for common treatments
- Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
- Azithromycin Protects Against Hyperoxic Lung Injury in Neonatal Rats
- Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants
- Circulating glucocorticoid bioactivity and serum cortisol concentrations in premature infants: the influence of exogenous glucocorticoids and clinical factors
- Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood
- Prevention of Necrotizing Enterocolitis in Preterm Infants: A 20-Year Experience
- Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants
- Early Neonatal Hydrocortisone: Study Rather Than Treat
- Hemodynamic Changes After Low-Dosage Hydrocortisone Administration in Vasopressor-Treated Preterm and Term Neonates
- Reopening the Debate on Corticosteroids: In Reply
- Reopening the Debate on Corticosteroids: In Reply
- Neurodevelopmental and Respiratory Follow-up Results at 7 Years for Children From the United Kingdom and Ireland Enrolled in a Randomized Trial of Early and Late Postnatal Corticosteroid Treatment, Systemic and Inhaled (the Open Study of Early Corticosteroid Treatment)
- Reopening the Debate on Corticosteroids: To the Editor
- Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative
- Fetal Adrenal Development: Implications For Lung Development and Postnatal Disease
- Summary Proceedings From the Bronchopulmonary Dysplasia Group
- Hydrocortisone and Vasopressor-Resistant Shock in Preterm Neonates
- A Double-Blind, Randomized, Controlled Study of a "Stress Dose" of Hydrocortisone for Rescue Treatment of Refractory Hypotension in Preterm Infants
- Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial
- Pharmacology Review: Intravenous Ibuprofen for Preterm Newborns
- Randomized, Controlled Trial of Dexamethasone in Neonatal Chronic Lung Disease: 13- to 17-Year Follow-up Study: I. Neurologic, Psychological, and Educational Outcomes
- Chronic Lung Disease and Randomized Interventional Trials: Status in 2005
- Weighing Statistical Certainty Against Ethical, Clinical, and Biologic Expediency: The Contributions of the Watterberg Trial Tip the Scales in the Right Direction
- Weighing Statistical Certainty Against Ethical, Clinical, and Biologic Expediency: The Contributions of the Watterberg Trial Tip the Scales in the Right Direction: In Reply
- Early Closure of the Watterberg Trial